LifeQ, Inc.

LifeQ, Inc. is a pioneering force in the health care industry, providing advanced biometrics and health information derived from wearable devices to empower individuals to lead healthier lives. Founded in 2014, LifeQ's solutions offer a comprehensive 24/7 view into the body, transcending the capabilities of traditional smartwatches, and generating high-quality biometrics for consumers, athletes, and those facing acute or chronic illnesses. The company's groundbreaking technology enables early detection and prevention of a wide range of health issues, including cardiovascular disease, COVID, respiratory disorders, and sleep apnea. Notably, its innovative approach is reshaping the future of healthcare by facilitating swift disease detection and treatment. In its most recent funding round, LifeQ secured a substantial $47.00M Series A investment on 26 May 2021, with participation from a diverse group of investors including Allectus Capital, Allen & Company, 4Di Capital, Delos Capital, Lireas Holdings, Bremer Investments, Hannover Re, Tenhong Holdings, Nedbank Corporate and Investment Banking, and Stellar Capital Partners. With its far-reaching impact on wearable device companies, insurers, health-tech firms, clinicians, researchers, and analytics companies, LifeQ's powerful disease detection and prevention capabilities position it as a driving force in shaping the future of healthcare.